Term ends Sep 2, 2032 · High confidence
20-year base term ends Jul 26, 2031
Held by Ucb Pharma, S.A.
Filed Dec 22, 2015 as application 14/977,688 · Granted Jan 29, 2019
Base term plus 431 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2011
2032
Clock starts
Jul 26, 2011
Jul 26, 2011
Term ends
Sep 2, 2032
Sep 2, 2032
Granted
Jan 29, 2019
Jan 29, 2019
431
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 9,309,280.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 431 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 26, 2011, when application PCT/EP2011/062837, the earliest non-provisional in its chain, was filed (this one was filed Dec 22, 2015) | Jul 26, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +431 days, USPTO patent term adjustment record | Sep 29, 2032 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,309,280) | capped to Sep 2, 2032 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 2, 2032 | High confidence |
Partial family
| Application PCT/EP2011/062837 | PCT application no patent term | no patent term |
| US 9,309,280 | In force Sep 2032 | Sep 2032 |
| US 10,189,897 | this patent Sep 2032 | Sep 2032 |
| US 11,339,214 | In force Sep 2032 | Sep 2032 |
| Application 17/750,444 | Pending not computed | not computed |
Partial: 1 of the 5 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 22, 2015 Reel 37349, frame 95 | Spitali, Mariangela; Symmons, Jonathan; Whitcombe, Richard; Pearce-higgins, Mark Robert | Celltech R&D Ltd. | Assignment of Assignor's Interest |
| Dec 22, 2015 Reel 37349, frame 116 | Celltech R&D Ltd. | Ucb Pharma, S.a. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Sep 2032
Term ends Sep 2, 2032. Maintenance fees still fall due before then
Note
The 431 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 9,309,280.
Citations
5
later US patents cite this one
That is above the median of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.